Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2010
02/23/2010US7666454 Antiwrinkle agents and moisturizers containing neryl acetate
02/23/2010US7666446 Oral formulation for delivery of poorly absorbed drugs
02/23/2010US7666445 Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
02/23/2010US7666444 Organic amine salt of closantel; administered with carrier and optionally macrocyclic lactone; bioavailability, blood concentration; veterinary medicine
02/23/2010US7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
02/23/2010US7666413 For subcutaneous administration; hypertonic; useful for preventing self-association of reconstituted lyophilized formulations
02/23/2010US7666410 incorporates a composition containing alumina to which various functional materials containing particular moieties may be adsorbed onto the alumina and used as desired such as pharmaceuticals, xenobiotics, anti-microbial agents, anti-viral agents
02/23/2010US7666409 Soy sauce comprising 3.55% or less by weight of sodium, 0.5-4.2% by weight of potassium, and 0.05-10% by weight of a food material having an antihypertensive effect, wherein remaining portion of liquid seasoning is adapted by incorporation of a substance having nitrogen content of 1.6% or more
02/23/2010US7666398 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
02/23/2010US7666396 High speed dissolving; applying to lips; mixture of water soluble film forming polymer, moisturizer and solidifying agent
02/23/2010US7666395 Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
02/23/2010US7666337 Polyethylene oxide-based films and drug delivery systems made therefrom
02/23/2010US7666307 reduction of the size of solid drug particles in aqueous suspensions by conduction of the suspensions through magnetic fields; improved bioavailability in animals and in human, both in vitro and in vivo
02/23/2010US7666225 Spinal disc nucleus pulposus implant
02/23/2010US7666223 Stent with drug coating
02/23/2010US7666179 Medical devices having porous regions for controlled therapeutic agent exposure or delivery
02/23/2010CA2539027C Pharmaceutical combinations of hydrocodone and naltrexone
02/23/2010CA2520026C High drug load mesalazine sachet
02/23/2010CA2498489C Method for subretinal administration of therapeutics including steroids;method for localizing pharmacodynamic action at the choroid and the retina; and related methods for treatment and/or prevention of retinal diseases
02/23/2010CA2473312C Non-gelatin capsule shell formulation comprising iota-carrageenan and kappa-carrageenan
02/23/2010CA2470492C Aqueous compositions containing metronidazole
02/23/2010CA2448596C Topical treatments using alkanolamines
02/23/2010CA2447081C An aerosol forming device for use in inhalation therapy
02/23/2010CA2400826C Methods and compositions for treating intervertebral disc degeneration
02/23/2010CA2387710C Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same
02/23/2010CA2378945C Multi-dose erythropoietin formulations
02/23/2010CA2378880C Solutions and methods for inhibition of pain, inflammation and cartilage degradation
02/23/2010CA2374102C Compositions containing creatine in suspension
02/23/2010CA2353448C Improvements in or relating to powders
02/23/2010CA2344173C Immunogenic liposome compositions
02/18/2010WO2010019915A1 Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders
02/18/2010WO2010019769A1 Cross-linked polymer network formed by sequential cross-linking
02/18/2010WO2010019718A2 Carrier nanoparticles and related compositions, methods and systems
02/18/2010WO2010019649A2 Active polymer compositions
02/18/2010WO2010019643A2 An extracorporeal cell-based therapeutic device and delivery system
02/18/2010WO2010019467A1 System and method for small particle size drug delivery using hypoxic mixture of helium and oxygen
02/18/2010WO2010019413A2 Composite particles having an antioxidant-based protective system, and topical compositions comprising the same
02/18/2010WO2010019279A1 Pharmaceutical compositions configured to deter dosage form splitting
02/18/2010WO2010019226A1 Intravaginal devices with a rigid support, methods of making, and uses thereof
02/18/2010WO2010018855A1 Drug sustained release agent, adsorbent, functional food, mask, and adsorptive sheet
02/18/2010WO2010018777A1 Odor-controlling method
02/18/2010WO2010018723A1 Liquid indigo carmine preparation
02/18/2010WO2010018614A1 Hydrophilic amino acid-containing preparation having improved taste
02/18/2010WO2010018596A2 Stable injectable oil-in-water docetaxel nanoemulsion
02/18/2010WO2010018591A1 Multi coloured tablets
02/18/2010WO2010018418A1 Formulation based on micronized clinoptilolite as therapeutic agent providing highly bioavailable silicon
02/18/2010WO2010018408A2 Pharmaceutical compositions
02/18/2010WO2010018339A1 Colorless antiseptic solution for skin use
02/18/2010WO2010018286A1 Ph-sensitive dendritic polymeric micelles
02/18/2010WO2010018223A1 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions
02/18/2010WO2010018222A1 Nanocrystal nano-emulsion
02/18/2010WO2010018175A2 Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
02/18/2010WO2010018159A1 Pharmaceutical compositions
02/18/2010WO2010018003A2 Carrier system for biological agents containing organosilicon compounds and uses thereof
02/18/2010WO2010017965A2 SOLID LIPID MICROCAPSULES CONTAINING hGH
02/18/2010WO2010017948A2 Pharmaceutical compositions with modified release properties comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl)-methyl)-2-thiophencarboxamid
02/18/2010WO2010017918A2 Amorphous ambrisentan
02/18/2010WO2010017917A1 Pharmaceutical formulation for lowering pulmonary blood pressure
02/18/2010WO2010017885A2 Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl- penta-2,4-dienoic acid as a cosmetic
02/18/2010WO2010017821A1 Coated tablets with a remaining degradation surface over the time8
02/18/2010WO2010017743A1 The injectable sustained-release formulation of lhrh antagonists and the preparation thereof
02/18/2010WO2010017623A1 Antimicrobial silver solutions
02/18/2010WO2010017614A1 Mucoadherents compositions and their use
02/18/2010WO2010017605A2 Method of standardization of injectable medicines and their diluents
02/18/2010WO2010017570A2 Pharmaceutical form comprising tetrahydrobiopterin
02/18/2010WO2009153346A3 Stabilization of amorphous drugs using sponge-like carrier matrices
02/18/2010WO2009140341A3 Atorvastatin compositions
02/18/2010WO2009137087A3 A method for preventing or alleviating the noxious effects resulting from toxicant exposure
02/18/2010WO2009134076A3 Combined composition for controlled-release of angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor
02/18/2010WO2009129509A3 Methods and compositions for treating post-operative pain comprising a local anesthetic
02/18/2010WO2009129453A3 Clonidine formulation in a polyorthoester carrier
02/18/2010WO2009129437A3 Methods and compositions for treating post-operative pain comprising clonidine
02/18/2010WO2009126302A3 Stabilized oleosome preparations and methods of making them
02/18/2010WO2009126301A3 Controlled release of active agents from oleosomes
02/18/2010WO2009118356A3 Preparation method for solid dispersions
02/18/2010WO2009112769A3 Pharmaceutical dye extracted from cranberry with high proanthocyanidin a concentration
02/18/2010WO2009111551A3 Hemorrhoid treatment device
02/18/2010WO2009083203A3 Topical application and formulation of erythropoietin for skin wound healing
02/18/2010WO2009077769A3 Carrier
02/18/2010WO2009046281A3 Injectable particles
02/18/2010WO2009037310A3 Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules
02/18/2010WO2009027506A3 Local topical administration formulations containing fipronil
02/18/2010WO2008132712A3 Combination pharmaceutical compositions
02/18/2010US20100043095 Production, formulation, and uses of stable liquid harpin protein formulations
02/18/2010US20100042043 Automatic drug administration with reduced power consumption
02/18/2010US20100041744 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
02/18/2010US20100041624 Buprenorphine formulations for intranasal delivery
02/18/2010US20100041605 Use of VEGF-C or VEGF-D in Reconstructive Surgery
02/18/2010US20100041152 Methods for encapsulating plasmids in lipid bilayers
02/18/2010US20100040727 Method for Improving Uniformity of Content in Edible Film Manufacturing
02/18/2010US20100040712 Throat spray
02/18/2010US20100040697 Cosmetic product, nanoparticles for cosmetics, and powder for cosmetics
02/18/2010US20100040696 Composite Particles Having An Antioxidant-Based Protective System, And Topical Compositions Comprising The Same
02/18/2010US20100040695 Methods for providing nutritional products for customized energy intake
02/18/2010US20100040694 Low-molecular weight, water-soluble chitosan nanoparticle for gene delivery with folic acid conjugaed thereto as target ligand and preparation method thereof
02/18/2010US20100040693 Silica capsules having nano-holes or nano-pores on their surfaces and method for preparing the same
02/18/2010US20100040692 Two phase bioactive formulations
02/18/2010US20100040691 Pharmaceutical compositions comprising methotrexate
02/18/2010US20100040690 Adhesive mixture for transdermal delivery of highly plasticizing drugs
02/18/2010US20100040689 Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders
1 ... 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 ... 2991